Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Brain signals explain speech communication differences in autistic children July 16, 2026 Children of single mothers by choice show favorable birth outcomes September 22, 2026 WHO study sheds light on global maternal mortality crisis March 9, 2025